Wakefit, Park Medi World, Nephrocare, Corona Remedies: Four IPOs worth ₹3,700 cr to open next week
ADVERTISEMENT
The upbeat momentum in the primary market is set to continue in the second week of December, with four mainboard IPOs collectively aiming to raise over ₹3,735 crore set to hit Dalal Street. In the first week alone, Meesho, Aequs, and Vidya Wires mobilised ₹6,642 crore through their public issues. The trio is scheduled to debut on the BSE and NSE on December 10.
Next week, four IPOs—including Wakefit Innovations and three healthcare-focused issues from Nephrocare Health Services, Park Medi World, and Corona Remedies—will open for subscription between December 8 and December 12, 2025.
Wakefit Innovations, the largest issue of the week, will open its ₹1,288.89-crore IPO on December 8 and close on December 10. The Bengaluru-based home and sleep solutions company has set a price band of ₹185–195 per share, aiming at a market valuation of around ₹6,300 crore.
The IPO comprises a fresh issue of 1.93 crore shares aggregating to ₹377.18 crore and an offer for sale (OFS) of 4.68 crore shares by promoters and existing investors, amounting to ₹911.71 crore. Ahead of its IPO, the company raised ₹56 crore in a pre-IPO round from DSP India Fund and 360 ONE Equity Opportunities Fund, allotting 28.71 lakh shares at ₹195 per share. DSP India Fund invested ₹40 crore, while 360 ONE infused ₹16 crore.
November 2025
The annual Fortune India special issue of India’s Best CEOs celebrates leaders who have transformed their businesses while navigating an uncertain environment, leading from the front.
The ₹655.37-crore public issue of Corona Remedies will also open for bidding on December 8 and the three-day issue will close on December 10. The IPO, having a price band of ₹1,008–1,062 per share, is entirely an offer for sale of 0.62 crore shares.
On December 10, two more healthcare-focused IPOs will hit the market, with Nephrocare Health Services looking to raise ₹871.05-crore at a price band of ₹438–460 per share. The company, which provides end-to-end dialysis care through a wide network of clinics across India, looks to raise ₹353.40 crore via fresh issue and another ₹517.64 crore through offer for sale.
Park Medi World will open its ₹920-crore IPO with a price band of ₹154–162 per share, also closing on December 12. The issue is a combination of fresh issue of 4.75 crore shares aggregating to ₹770 crore and OFS of 0.93 crore shares aggregating to ₹150 crore. The company is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of September 30, 2024.